BioReliance® Biosafety Testing and Analytical and Bioassay Testing
Choosing the right partner for your analytical and biosafety testing is critical in the race to approval. Our BioReliance® testing services offer exceptional, risk-mitigating solutions with technical and regulatory expertise, to help you bring life-changing drugs to market. Our testing and manufacturing services span the product cycle from early pre-clinical development to licensed production. Partner with us to meet your needs for Biologics Safety Testing, Analytical and Bioassay testing, and Biomanufacturing Services.
Ready to begin your project?
We've been shaping the industry for decades and are proud to be the first in the world to:
- Develop polio vaccine biosafety protocols in 1955
- Develop mouse antibody test in collaboration with the U.S. NIH in 1960
- Characterize the first U.S. national stem cell banks in 2007
Support for all phases of biopharmaceutical drug development
Whatever stage of the biopharma development process you’re in, our leading cGMP-compliant testing services and regulatory knowledge can help you progress your therapeutic from discovery to release.
This table represents the most likely timing for when a service will be needed during development.
*Analytical and Bioassay testing
**Support for IND and BLA enabling studies
∆Including Next Generation Sequencing and the Blazar® platform for rapid methods
With comprehensive and integrated packages of services, we support your traditional and novel modality development.
Related Resources
- Flyer: Next Generation Sequencing in Biosafety Testing and Product Characterization
NGS is a transformative method enabling advanced analysis of biologic therapeutics, including monoclonal antibodies.
- Reference Guide: Accelerating Bulk Harvest Release Testing: A Complete Set of Rapid Methods for Adventitious Agent Detection
Alternative methods offer a faster turnaround time which are needed to address the increasing pressures on manufacturing speed and efficiency.
- Flyer: Expert Partnership Contract Testing Services
Discover comprehensive services support your development journey.
- Flyer: Next Generation Sequencing In biosafety testing & product characterization
Learn about regulatory support for the use of NGS methods.
- Flyer: Accelerating CHO Bulk Harvest Testing Requires Rapid Methods
An alternative to the in vitro virus assay for bulk harvest material.
- Flyer: Leave No Gap in Your AAT Strategy
De-risk IND filings with a complete adventitious agent testing (AAT) package.
- Flyer: Ensure complete characterization of your rodent cell line
The Blazar® tNGS Rodent Virus Panel detects species-specific viruses during cell line characterization.
- Flyer: Discover cell line NGS AAT enhanced
Keep regulatory confidence, gain modern objectivity for your cell line characterization.